Tanabe Pharma America Completes RADICAVA Transfer To Shionogi
01 Apr 2026 //
PR NEWSWIRE
Tanabe Pharma America Showcases ALS Research At MDA 2026
05 Mar 2026 //
PR NEWSWIRE
Experimental Drug Scores In Ph. 3 For Painful Sunlight Disorders
22 Jan 2026 //
FIERCE BIOTECH
Tanabe Pharma America Showcases Edaravone`s ALS Mechanisms
04 Dec 2025 //
PR NEWSWIRE
Mitsubishi Tanabe Pharma America Is Now Tanabe Pharma America
01 Dec 2025 //
PR NEWSWIRE
Mitsubishi Tanabe Pharma To Unveil Investigational ND0612 Data
03 Oct 2025 //
PR NEWSWIRE
Mitsubishi Tanabe Pharma America To Showcase Eight ALS Research
02 Oct 2025 //
PR NEWSWIRE

Market Place
Sourcing Support